These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21669253)

  • 41. Anti-CD25 monoclonal antibody Fc variants differentially impact regulatory T cells and immune homeostasis.
    Huss DJ; Pellerin AF; Collette BP; Kannan AK; Peng L; Datta A; Wipke BT; Fontenot JD
    Immunology; 2016 Jul; 148(3):276-86. PubMed ID: 27012310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
    Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
    Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3.
    Wang L; Liu Y; Han R; Beier UH; Bhatti TR; Akimova T; Greene MI; Hiebert SW; Hancock WW
    J Clin Invest; 2015 Mar; 125(3):1111-23. PubMed ID: 25642770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-2: a two-faced master regulator of autoimmunity.
    Sharma R; Fu SM; Ju ST
    J Autoimmun; 2011 Mar; 36(2):91-7. PubMed ID: 21282039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1-mediated autoimmunity: evidence from EAE in iNOS KO mice.
    Dalton DK; Wittmer S
    J Neuroimmunol; 2005 Mar; 160(1-2):110-21. PubMed ID: 15710464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.
    DuPage M; Chopra G; Quiros J; Rosenthal WL; Morar MM; Holohan D; Zhang R; Turka L; Marson A; Bluestone JA
    Immunity; 2015 Feb; 42(2):227-238. PubMed ID: 25680271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fatal autoimmunity results from the conditional deletion of Snai2 and Snai3.
    Pioli PD; Chen X; Weis JJ; Weis JH
    Cell Immunol; 2015 May; 295(1):1-18. PubMed ID: 25732600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Bornschein S; Cauwe B; Schönefeldt S; Bossuyt X; Matthys P; Baron F; Wouters C; Liston A
    J Allergy Clin Immunol; 2016 Jul; 138(1):200-209.e8. PubMed ID: 26947179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of interleukin-17 receptor signaling on innate and adaptive immunity during central nervous system bacterial infection.
    Vidlak D; Kielian T
    J Neuroinflammation; 2012 Jun; 9():128. PubMed ID: 22704602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of Fas in the immune system biology of IL-2R alpha knockout mice: interplay among regulatory T cells, inflammation, hemopoiesis, and apoptosis.
    Sharma R; Bagavant H; Jarjour WN; Sung SS; Ju ST
    J Immunol; 2005 Aug; 175(3):1965-73. PubMed ID: 16034141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-2Rbeta links IL-2R signaling with Foxp3 expression.
    Soper DM; Kasprowicz DJ; Ziegler SF
    Eur J Immunol; 2007 Jul; 37(7):1817-26. PubMed ID: 17559173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo expansion of regulatory T cells with IL-2/IL-2 mAb complexes prevents anti-factor VIII immune responses in hemophilia A mice treated with factor VIII plasmid-mediated gene therapy.
    Liu CL; Ye P; Yen BC; Miao CH
    Mol Ther; 2011 Aug; 19(8):1511-20. PubMed ID: 21468007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells.
    Yu A; Malek TR
    J Immunol; 2006 Oct; 177(8):5115-21. PubMed ID: 17015695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
    Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p27(Kip1) inhibits systemic autoimmunity through the control of Treg cell activity and differentiation.
    Iglesias M; Postigo J; Santiuste I; González J; Buelta L; Tamayo E; Merino J; Merino R
    Arthritis Rheum; 2013 Feb; 65(2):343-54. PubMed ID: 23124840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SHARPIN controls the development of regulatory T cells.
    Redecke V; Chaturvedi V; Kuriakose J; Häcker H
    Immunology; 2016 Jun; 148(2):216-26. PubMed ID: 26931177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes.
    Ramanathan S; Dubois S; Chen XL; Leblanc C; Ohashi PS; Ilangumaran S
    J Immunol; 2011 May; 186(9):5131-41. PubMed ID: 21430227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CNS-Specific Synthesis of Interleukin 23 Induces a Progressive Cerebellar Ataxia and the Accumulation of Both T and B Cells in the Brain: Characterization of a Novel Transgenic Mouse Model.
    Nitsch L; Zimmermann J; Krauthausen M; Hofer MJ; Saggu R; Petzold GC; Heneka MT; Getts DR; Becker A; Campbell IL; Müller M
    Mol Neurobiol; 2019 Dec; 56(12):7977-7993. PubMed ID: 31154574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity.
    Raverdeau M; Christofi M; Malara A; Wilk MM; Misiak A; Kuffova L; Yu T; McGinley AM; Quinn SM; Massilamany C; Reddy J; Forrester JV; Mills KH
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30894405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.